검색어: kompliciranimi (슬로베니아어 - 영어)

ena študija je primerjala zdravilo doribax z levofloksacinom pri skupaj 753 bolnikih s kompliciranimi okužbami sečnega trakta.
one study compared doribax with levofloxacin in 753 patients with complicated urinary tract infections.

zdravilo tygacil je antibiotik, ki se uporablja za zdravljenje odraslih s kompliciranimi okužbami kože ali mehkih tkiv (podkožnega tkiva) in kompliciranimi trebušnimi okužbami.
tygacil is an antibiotic that is already used to treat adults with complicated infections of the skin or soft tissue (the tissue below the skin) and complicated infections in the abdomen.

zdravilo doribax je bilo pri zdravljenju okužb prav tako učinkovito kot drugi antibiotiki: • skupni rezultati obeh študij, pri katerih so sodelovali bolniki z nozokomialno pljučnico, so pokazali, da je ozdravelo 75% bolnikov, ki so prejemali zdravilo doribax (195 od 260), v primerjavi z 72% bolnikov, ki so prejemali piperacilin/ tazobaktam ali imipenem (174 od 241); • skupni rezultati obeh študij, pri katerih so sodelovali bolniki s kompliciranimi okužbami trebuha, so pokazali, da je ozdravelo 85% bolnikov, ki so prejemali zdravilo doribax (275 od 325), v primerjavi s 84% bolnikov, ki so prejemali meropenem (260 od 306); • pri kompliciranih okužbah sečnega trakta, je ozdravelo 82% bolnikov, ki so prejemali zdravilo doribax (230 od 280), v primerjavi z 83% bolnikov, ki so prejemali levofloksacin (221 od 265).
doribax was as effective as the other antibiotics in treating the infections: • looking at the results of the two studies in nosocomial pneumonia taken together, 75% of the patients receiving doribax were cured (195 out of 260), compared with 72% of the patients taking piperacillin/ tazobactam or imipenem (174 out of 241); • looking at the results of the two studies of complicated abdominal infections taken together, 85% of the patients receiving doribax were cured (275 out of 325), compared with 84% of the patients receiving meropenem (260 out of 309); • in complicated urinary tract infections, 82% of the patients receiving doribax were cured (230 out of 280), compared with 83% of the patients receiving levofloxacin (221 out of 265).